The London Clinic, 120 Harley Street, London, W1G 7JW

Publications

Mr Mark Feneley Book Cover
 
  • G Boustead and M R Feneley. Pelvic Exenterative Surgery and Technological Developments for Palliation of Malignant Disease, Clinical Oncology (In Press)
  • R Hamid, M R Feneley and J Shah. Management of Oncological and Latrogenic Urinary Incontinence in Malignant Disease. Clinical Oncology (In Press)
  • S Minhas, C J Shukla, M Shabbir, M R Feneley, S Withey, A Muneer. Palliation of Male Genital Malignancy. Clinical Oncology (In Press)
  • M R Feneley. Book Review – Screening for Prostate Cancer. BJU Int . (In Press).
  • H Payne, A Swampillai and M R Feneley. Improving quality of life in men with advanced prostate cancer. Mimms, Special Supplement on Prostate Cancer (2009).
  • M R Feneley. Book Review - Prostate Biopsy: Indications, Techniques and Complications. BJU Int (2009), 104 (1), 123.
  • M R Feneley. Prostate Cancer: Preface. Surg Oncol (2009), 18S (3), 181-182.
  • S Sriprasad, M R Feneley, P M Thompson. History of prostate cancer treatment. Surg Oncol (2009), 18 (3), 185-191.
  • C L Foley, M R Feneley. The clinical significance and therapeutic implications of extraprostatic invasion. Surg Oncol (2009), 18 (3), 203-212.
  • J Nariculam, A Freeman, S Bott, P Munson, N Cable, N Brookman-Amissah, M Williamson, R S Kirby, J Masters and M R Feneley. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors Asian J Androl (2009), 11 (1), 109-118.
  • N Borley and M R Feneley. Prostate cancer: diagnosis and staging. Asian J Androl. (2009), 11 (1), 74-80.
  • J Kalsi, S J Harland, M R Feneley. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma. Expert Opin Drug Deliv (2008), 5 (1), 137-145.
  • O G Wong, T Nitkunan, I Oinuma, C Zhou, V Blanc, R S Brown, S R Bott, J Nariculam, G Box, P Munson, J Constantinou, M R Feneley, H Klocker, S A Eccles, M Negishi, A Freeman, J R Masters, M Williamson. Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci U S A (2007), 104 (48),19040-19045.
  • N Brookman-Amissah, J Nariculam, A Freeman, M Willamson, R S Kirby, J R Masters and M R Feneley. Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse. Cancer Genet Cytogenet (2007), 179 (2):118-126.
  • Various articles on prostate problems and cycling, published in Cycling Weekly, 2007
  • A Traish, A T Guay, R F Spark, Testosterone Therapy in Women Study Group (incl M R Feneley). Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary. J Sex Med (2007), 4 (5), 1223-1234.
  • M R Feneley. Book Review - Urological emergencies. a practical guide. BJU Int (2006), 97 (1), 195.
  • S R Bott, J R Masters, M C Parkinson, R S Kirby, M R Feneley, J Hooper and M Williamson. Allelic imbalance and biochemical outcome after radical prostatectomy. Prostate Cancer Prostatic Dis 2006; 9, 160-168.
  • D C Gould, M R Feneley, R S Kirby. Prostate-specific antigen testing in hypogonadism: implications for the safety of testosterone-replacement.therapy. BJU Int. (2006), 98, 1-4. D C Gould, M R Feneley, R S Kirby. Prostate-specific antigen testing in hypogonadism: implications for the safety of testosterone-replacement.therapy. BJU Int. (2006), 98, 1-4.
  • J Constantinou and M R Feneley PSA testing: an evolving relationship with prostate cancer screening. Prostate Cancer Prostatic Dis. (2006), 9, 6-13.
  • N Brookman-Amissah C E Duchesnes, M P Williamson, Q Wang, A Ahmed, M R Feneley, A Mackay, A Freeman, A Alan, K Fenwick, M Iravani, B Weber, A Ashworth and J R Masters. Genome-wide screening for genetic changes in prostate cancer cell lines using CGH arrays. Prostate Cancer Prostatic Dis. (2005), 8, 335-43.
  • M Harada, J Woodhams, A J MacRobert, M R Feneley, H Kato and S G Bown . The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon. Journal of Photochemistry and Photobiology (2005), 79, 223-230.
  • I Laczko, D L Hudson, A Freeman, M R Feneley, J R Masters, Comparison of the Zones of the human prostate with the seminal vesicle : morphology, immunohistochemistry, and cell kinetics. Prostate. 2005 Feb 15;62(3):260-6.
  • Evolution of the Techniques. Eurocommunica Ltd. Cancer Topics, 12 (2), 6-9. (2004).
  • M R Feneley, P M Thompson, R S Kirby. Radical Surgical Treatment of Prostate Cancer:
  • P Hegarty and M R Feneley. Testosterone replacement and the prostate gland. Bioscience Communications. Medicine Today (2004).
  • T Nitkunan and M R Feneley. Prostatic Intra-epithelial Neoplasia. Urological Cancer Abstracts (2004).
  • M R Feneley and S J Harland. Editorial. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a new standard of care? BJU Int. 2003 Dec;92(9):877-8.
    A C Yung, A Y Oner , J M Serfaty, M R Feneley, X Yang, E Atalar. Phased-array MRI of canine prostate using endorectal and endourethral coils. Magnetic Resonance Medicine (2003), 49, 710-5.
  • M R Feneley, S Brewster. Editorial. Opportunities and outcomes in early prostate cancer: a commentary on policy, patient perspectives, trials and strategies. BJU International (2003), 91, 177-8.
  • S Brewster, M R Feneley, R S Kirby. Letter: Prostate cancer screening and treatment. Rapid Response. Natural Experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ (2002).
  • M R Feneley and R Parkinson. The early detection of prostate cancer. CME Cancer Medicine (2002), 1 (1), 1-36.
  • W Kirkman, P Chen, R Schroeder, M R Feneley, R Rodriguez, T J Wickham, R King, J T Bruder. Transduction and apoptosis induction in the rat prostate using adenoviral vectors. Human Gene Therapy (2001).
  • M R Feneley, A W Partin. Predicting pathological stage of localized prostate cancer. Urologic Clinics of North America (2001), 28 (3), 443-458.
  • M R Feneley. Letter: Localised prostate cancer: addressing the challenge. Rapid Response. BMJ (2000).
  • M R Feneley, M Schoenberg. Bladder Sparing Strategies for Transitional Cell Carcinoma. Editorial. Urology (2000), 56 (4), 549-60.
  • A W Partin and M R Feneley. Radical retropubic prostatectomy - limitations in high risk disease. Innovations in the Therapy of Localized Prostate Cancer.
    American Society of Clinical Oncology (2000).
  • M R Feneley, M Schoenberg. Bladder Sparing Strategies for Transitional Cell Carcinoma. Editorial. Urology (2000), 56 (4), 549-60.
  • M R Feneley, J K Mellon. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer. Review article. Seminars in Urologic Oncology (2000), 18(4), 300-7.
  • M R Feneley, A W Partin. Diagnosis of localized prostate cancer: 10 years of progress. Current Opinion in Urology (2000), 10 (4), 319-27.
  • K E Britton, M R Feneley, H Jan, V U Chengazi, M Granowska. Prostate Cancer: the contribution of nuclear medicine. BJU Int (2000), Suppl 1, 135-42.
  • M R Feneley, P Landis, I Simon, E J Metter, C H Morrell, H B Carter, P C Walsh. Today men with prostate cancer have larger prostates. Urology. (2000), 56 (5), 839-42.
  • M R Feneley, H Jan, M Granowska, S J Mather, D Ellison, J Glass, M Coptcoat, R S Kirby, C Ogden, R T D Oliver, D F Badenoch, F I Chinegwundoh, V H Nargund, A M I Paris and K E Britton. Imaging with Prostate Membrane-Specific Antigen (PMSA) in Prostate Cancer. Prostate Cancer and Prostatic Diseases, (2000), 3, 47-52.
  • M G Berry, M R Feneley, P Domizio, K E Britton, H Jan, D F Badenoch. Evaluating the return of prostatic adenocarcinoma. Journal of the Royal Society of Medicine (1999), 91 (12), 641-3
  • M R Feneley, P Span, J Schalken, M Harper, K Griffiths and R S Kirby. Tissue effects of finasteride in patients with benign prostatic hyperplasia: a controlled, randomised study. Prostate Cancer and Prostatic Diseases, (1999), 2, 227-281.
  • M R Feneley, R C L Feneley. Funding research in urological training: the need for a future strategy and longer term strategies. Annals of the Royal College of Surgeons of England (1999), 81, 145-150.
  • M R Feneley. Does screening for prostate cancer identify clinically important disease? Annals of the Royal College of Surgeons of England (1999), 81, 207-214.
  • P N Span, M C W Voller, A G H Smals, F G J Sweep, J A Schalken, M R Feneley and R S Kirby. Selectivity of Finasteride as in vivo inhibitor of 5-alpha reductase isozyme enzymatic activity in human prostate. Journal of Urology (1999), 161, 332-337.
  • M R Feneley and P C Walsh. Incontinence after radical prostatectomy. Lancet (1999), 353, 2091-2092.
  • M R Feneley. Electrovaporisation of the prostate. Lancet (1998), 351, 999-1001.
  • M R Feneley and R C L Feneley. The contribution of research to urological training in the United Kingdom. British Journal of Urology (1998), 81, 193-198.
    M R Feneley, M P A Young, C Makunura, R S Kirby, M C Parkinson. Internet Uroweb EAU: http://www.bpc.nl/uroweb/oncoweb/prostate/posters/ki-67/index.html (1997).
  • M R Feneley, C Busch. Precursor lesions for prostate cancer and their clinical significance. Review Editorial. Journal of the Royal Society of Medicine (1997), 90, 533-539.
  • M E Laniado and M R Feneley. Urologists on the Internet: practical applications are now a reality. British Journal of Urology (1997), 80 (Suppl 3), 12-15.
  • M R Feneley, R S Kirby. Screening for prostate cancer: can it be justified? Journal of Managed Care (1997), 1, 61-66.
  • M R Feneley, J S A Green, P Bose, M P Young, W B Peeling, R S Kirby, M C Parkinson. The prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implications. Prostatic Cancer and Prostatic Diseases (1997), 1, 79-83.
  • M R Feneley, M K Pal, I Nockler, W F Hendry. Varicocele embolisation versus ligation: venographic findings and causes of failure. British Journal of Urology (1997), 80, 642-6.
  • V U Chengazi, M R Feneley, D Ellison, C C Nimmon, M Salteri, S J Mather, M Granowska, A Granowski, R S Kirby, K E Britton. Imaging prostate cancer with technetium-99m-7E11-C5.3. The Journal of Nuclear Medicine (1997), 38, 675-682.
  • M R Feneley, M C Parkinson. The clinical importance of prostatic intra-epithelial neoplasia. Current Medical Literature: Prostatic disease. (1997), 1 (1), 4-6.
  • M R Feneley, M C Parkinson. The clinical importance of prostatic intra-epithelial neoplasia. Current Medical Literature: Urology. (1997), 3 (1), 3-5.
    R S Kirby and M R Feneley. Tissue effects of 5-alpha-reductase inhibitors. Prospectives (1997), 7 (5), 1-4.
  • M R Feneley, M C Parkinson. Editorial: Biopsy diagnosis of prostatic cancer - current areas of concern. Journal of Clinical Pathology (1996), 50, 265-6.
  • M R Feneley, D A Gillatt, M Hehir, R S Kirby. Letter. Radical prostatectomy from three UK centres. British Journal of Urology (1997), 79, 303-4.
  • M R Feneley. Key Reviews Internet site: http://www.uroreviews.org/. 1996 - 2002.
  • M R Feneley, D A Gillatt, M Hehir, R S Kirby. A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. British Journal of Urology (1996), 78, 911-20.
  • M R Feneley, M C Parkinson. The interpretation of prostatic needle biopsy specimens. Prospectives (1996), 6, 5-8.
  • M R Feneley, M P A Young, C Makunura, R S Kirby, M C Parkinson. Ki-67 expression in early prostate cancer and associated pathological lesions. Journal of Clinical Pathology (1996), 49, 741-8.
  • M R Feneley, W D Dunsmuir, J Bryan, R S Kirby. Reproducibility of uroflow measurements: experience during a double blind placebo controlled study of Doxazosin in benign prostatic hyperplasia. Urology (1996), 47, 658-671.
  • M R Feneley, V U Chengazi, R S Kirby, C C Nimon, M Granowska, S J Mather, D Ellison, A R Granowski, K E Britton. Prostatic immune-scintigraphy: preliminary results using technetium-labeled monoclonal antibody CYT-351. British Journal of Urology (1996), 77, 373-381.
  • W Dunsmuir, M R Feneley, D A Corry, J Bryan, R S Kirby. The day-to-day variation (test-retest reliability), of residual urine measurement. British Journal of Urology (1996), 77, 192-193.
  • M R Feneley, R S Kirby, M C Parkinson. Prostatic malignancy following sclerotherapy: a diagnostic pitfall. British Journal of Urology (1996), 77, 157-158.
  • M R Feneley. Study finds high prevalence of high grade PIN in UK; effects on screening programs, re-biopsy policy seen. Urology Grand Rounds, (1996), 1, 13.
  • M R Feneley, J Mooibroeck, E Chartier-Kastler, H U Eickenberg (Eds). Urology Options No.4. Conference Report. 3rd International Consultation on BPH, Monaco (1995), Yamanouchi.
  • M R Feneley, R S Kirby. Reproducibility of Uroflow recordings. European Urology Today (1995), 5, 6-7.
  • R S Kirby and M R Feneley. Reproducibility of uroflow recordings evaluated. AUA Today (1995), 8 (5), 17.
  • M R Feneley, J A W Webb, A McLean, R S Kirby. Letter: Staging incidental carcinoma of the prostate. British Journal of Urology (1995), 76, 526-527.
  • J A Vale, M R Feneley, W R Lees, R S Kirby. Venous leak surgery: long-term follow-up of patients undergoing excision and ligation of the deep dorsal vein of the penis. British Journal of Urology (1995), 76, 192-5.
  • M R Feneley, J R Puddefoot, C Sowter, G Slavin, S Xia, R S Kirby, G P Vinson. Zonal biochemical and morphological characteristics in BPH. British Journal of Urology (1995), 75, 608-613.
  • M R Feneley, J A W Webb, A McLean, R S Kirby. Post-operative serial prostate specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate. British Journal of Urology (1995), 75, 14-20.
  • M R Feneley, M G Kirby, T McNicholas, A McLean, J A W Webb, R S Kirby. Screening for carcinoma of the prostate in general practice. Cancer Surveys (1995), 23, 115-125.
  • R S Kirby, M G Kirby, M R Feneley, T McNicholas, A McLean, J A W Webb. Screening for carcinoma of the prostate: a GP based study. British Journal of Urology (1994), 74, 64-71.
  • M R Feneley and R S Kirby. Counseling men with prostate cancer. Geriatric Medicine (1994), 24, 43-46.
  • M R Feneley, R S Kirby, M C Parkinson. Letter: Screening for prostate cancer. Lancet (1994), 343, 1436-1437.
  • M R Feneley, P Murthy. Acute bilateral vestibulo-cochlear dysfunction following occipital fracture. Journal of Laryngology and Otology (1994), 108, 54-56.
  • M R Feneley, S Liu, P D Miller, R S Kirby. Condylomata acuminata involving the entire urethra: a case report. British Journal of Urology (1992), 69, 218-219.
  • M R Feneley, N I Garlick, P D Moynagh. Accurate data collection for medical audit: problems and a practical solution. Medical Audit News (1992), 2, 42-43.
  • G J Burton, M R Feneley. Capillary volume fraction is the principle determinant of villous membrane thickness in the human placenta at term. Journal of Developmental Physiology (1992), 17, 39-45.
  • M R Feneley, G J Burton. Villous composition and membrane thickness in the human placenta at term: a stereological study using unbiased estimators and optimal fixation techniques. Placenta (1991), 12, 131-142.
  • M R Feneley, J W Fawcett, R J Keynes. The role of Schwann cells in the regeneration of axons through muscle basal lamina nerve grafts. Experimental Neurology (1991), 114, 275-285.

Whole Text Book

  • Handbook of Urological Surgery. Eds J Reynard, M Sullivan, K Turner, M R Feneley, N Armenakas, S Mark. OUP (2008).
  • Treatment Methods for Early and Advanced Prostate Cancer. Eds AW Partin, R S Kirby, J K Parsons, M R Feneley. Informa ( 2008).
  • Therapeutic Opportunities in Prostate Cancer, Eds M R Feneley and H Payne. Clinical Publishing. 2007.
  • Textbook of Prostate Cancer: Principles and Practice. Eds AW Partin, R S Kirby, M R Feneley, J K Parsons. Martin Dunitz. 2005. BMA Book Award Commendation, 2006.

Book Chapters

  • H Payne, R Davda, M R Feneley. Recent advances in hormonal therapy.
  • M R. Feneley, M Emberton and A R Mundy The prostate and benign prostatic hyperplasia. In Scientific Foundations of Urology (In Press)
    M R Feneley. Surgery for Urological Cancer. In Handbook of Urological Surgery. Eds J Reynard, M Sullivan, K Turner, M R Feneley, N Armenakas, S Mark. OUP, (2008).
  • J. Dawoodi, Z.S. Dovey and M R Feneley. The Assessment and Management of Urinary Incontinence due to Prostate Cancer and its treatment. In Treatment Methods for Early and Advanced Prostate Cancer. Eds AW Partin, R S Kirby, J K Parsons, M R Feneley. Informa, (2008).
  • M R Feneley, C Rees, L Moffat. Decision Making in Prostate Cancer. In Treatment Methods for Early and Advanced Prostate Cancer. Eds AW Partin, R S Kirby, J K Parsons, M R Feneley. Informa, (2008).
  • M R Feneley, H Payne High risk prostate cancer. In: Therapeutic Opportunities in Prostate Cancer, Clinical Publishing (2007)
  • M R Feneley, J Calleary. Surgical Anatomy of the Prostate. In Radical Prostatectomy Ed Kirby (2007)
  • M R Feneley and R S Kirby. Urological cancers in clinical practice. Pocket book. Surgical Treatment of Prostate Cancer. In Urological Cancers: Science and Treatment. Eds J Waxman et al. Springer-Verlag London Ltd (2005).
  • J. Dawoodi, Z.S. Dovey and M R Feneley. The Assessment and Management of Urinary Incontinence due to Prostate Cancer and its treatment. In Prostate Cancer: Principles and Practice. Eds AW Partin, R S Kirby, M R Feneley and J K Parsons. Martin Dunitz, (2005).
  • M R Feneley, C Rees, L Moffat. Decision Making in Prostate Cancer. In Prostate Cancer: Principles and Practice. Eds AW Partin, R S Kirby, M R Feneley and J K Parsons. Martin Dunitz (2005).
  • M R Feneley and R S Kirby. Surgical Treatment of Prostate Cancer. In Urological Cancers: Science and Treatment. Eds J Waxman et al. Springer-Verlag London Ltd (2005)
  • M R Feneley Basic Science. In Fast Facts - Urology Highlights, Health Press, Oxford. (2005)
  • M R Feneley, R S Kirby, R Lee, Alison Birtle, H Payne, C Parker. Localised prostate cancer: a case history-based look at the evidence/ In Treatment of Prostate Cancer. In: The Evidence for Urology. Eds C Dawson and G Muir. Tfm Publishing Limited, Shrewsbury, UK (2005)
  • M R Feneley, S R Bott. Prostatic needle biopsy in men with BPH: histopathological interpretation and clinical significance. In: A Textbook of BPH. 2nd Edition. Eds. R Kirby, J McConnell, J Fitzpatrick, C Roehrborn and P Boyle. Taylor and Francis (2005).
  • M R Feneley, R Parkinson. The PSA debate. In Men’s Health (2003).
  • M R Feneley, R Parkinson. The Early Detection of Prostate Cancer. CME Bulletin (2001).
  • R Parkinson and M R Feneley. Defining the window of opportunity for curative intervention: effectiveness and efficiency in the early detection of prostatic cancer and the role of case finding. In: Key Advances in the Effective Management of Prostatic Cancer Eds. M Wallace, D Ash, T Oliver and A Miles.
  • Aesculapius Medical Press, London (2001).
  • M R Feneley, A W Partin. PSA and radical prostatectomy. In: Prostate-Specific Antigen. Ed. M K Brawer. Marcel Dekker, New York. (2001).
  • M R Feneley and J P Gearhart. Surgical management of genital ambiguity. In: Pediatric And Adolescent Gynecology. 2nd Edition. Eds. Carpenter and Rock (2001).
  • M R Feneley, J P Gearhart. Cloacal exstrophy. In: The 5-Minute Urology Consult. Ed. L G Gomella, Lippincott Williams and Wilkins (2000).
  • M R Feneley and R S Kirby. Symptom evaluation and clinical presentation of BPH. In: Benign Prostatic Hyperplasia. Ed. P Narayan. Churchill Livingstone. (1998).
  • M R Feneley, M C Parkinson. The value of prostatic needle biopsy in benign prostatic hyperplasia. In: A Textbook of BPH. Eds. R Kirby, J McConnell, J Fitzpatrick, C Roehrborn and P Boyle. Isis Medical Media (1996).
  • Surgical Palliation. Supplement Issue. Clinical Oncology. Ed M R Feneley. (In Preparation, 2010)
  • Prostate Cancer: Clinical Outcomes in Clinical Practice. Surg Oncol (2009), 18S (3), 181-288 . Ed M R Feneley
  • MD Thesis, University of Cambridge
  • M R Feneley. The detection and assessment of early prostate cancer. M D Dissertation. University of Cambridge (1996).
Make an Enquiry

We will back to you within 48 hours. Required fields are marked *


  • Yes
  • No
Clinics & Visiting Hospitals
  • The London Clinic
  • 120 Harley Street
  • London
  • W1G 7JW
Map & Contact Details
  • The London Clinic
  • 20 Devonshire Place
  • London
  • W1G 6BW
Map & Contact Details
  • Wellington Hospital
  • Wellington Place
  • London
  • NW8 9LE
Map & Contact Details
  • Princess Grace Hospital (HCA)
  • 42-52 Nottingham Place
  • London
  • W1U 5NY
Map & Contact Details
Patients With Medical Insurance

We are recognised providers by all major health insurance companies.